EN #liver disease 10/19/26 AstraZeneca and insitro Sign AI-Powered Drug Discovery Agreement Pharmaceutical giant AstraZeneca has signed an agreement worth up to $1.5 billion with insitro for AI-based target discovery. News Artificial Intelligence
